Literature DB >> 35403375

Occupational engagement, fatigue, and upper and lower extremity abilities in persons with melorheostosis.

Kathleen Farrell1, Leora E Comis1, Morgan M Casimir1, Bonnie Hodsdon1, Rafael Jiménez-Silva1, Tiara Dunigan1, Timothy Bhattacharyya2, Smita Jha2,3.   

Abstract

INTRODUCTION: Melorheostosis is a rare bone disorder with limited literature that describes the effect of this disease on functional and motor abilities. As part of a natural history study, four outcome measures were administered to better understand the burden this disease has on a person's ability to engage in basic and instrumental activities of daily living.
OBJECTIVE: To investigate the relationship between functional engagement, fatigue, and motor ability in patients with melorheostosis.
DESIGN: Cross-sectional data gathered from a longitudinal natural history observational study.
SETTING: Rehabilitation department within a single institution. PARTICIPANTS: Forty-seven adult volunteers with melorheostosis were enrolled. Two participants were removed for failure to meet diagnosis eligibility. Thirty patients had lower extremity (LE) osteosclerotic bone lesions, 14 had upper extremity (UE) lesions, and one had lesions in both UEs and LEs.
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Activity Card Sort, Second Edition (ACS); Multi-Dimensional Fatigue Inventory; Lower Extremity Functional Scale; Upper Extremity Functional Index.
RESULTS: On the ACS, high-demand leisure (HDL) activities were the least retained (p < .001). Of the activities rated most important, HDL activities were the most likely to have been given up (27%). General fatigue (μ = 11.8) and physical fatigue (μ = 11.0) were the two most limiting fatigue constructs. There were moderate negative correlations with HDL activities compared to physical fatigue (r = -0.524, p < .001) and reduced activity fatigue (r = -0.58, p = .001). LE lesions had a large effect on completing LE tasks (d = 0.95) and UE lesions had a medium effect on completing tasks involving the UE (d = 0.69).
CONCLUSIONS: Patients with melorheostosis experience fatigue and low engagement in HDL activities. The results of this study underscore the importance of acknowledging activity domain, fatigue constructs, and lesion location to support and provide targeted evidence-based rehabilitative therapy. CLINICAL TRIAL REGISTRATION NUMBER: NCT02504879. Published 2022. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Year:  2022        PMID: 35403375      PMCID: PMC9548523          DOI: 10.1002/pmrj.12817

Source DB:  PubMed          Journal:  PM R        ISSN: 1934-1482            Impact factor:   2.218


  40 in total

1.  Atypical form of active melorheostosis and its treatment with bisphosphonate.

Authors:  Judit Donáth; Gyula Poór; Csaba Kiss; Béla Fornet; Harry Genant
Journal:  Skeletal Radiol       Date:  2002-10-29       Impact factor: 2.199

2.  Fatigue in knee and hip osteoarthritis: the role of pain and physical function.

Authors:  Gijs F Snijders; Cornelia H M van den Ende; Jaap Fransen; Piet L C M van Riel; Mirelle J P M Stukstette; Koen C Defoort; Marianne A Arts-Sanders; Frank H J van den Hoogen; Alfons A den Broeder
Journal:  Rheumatology (Oxford)       Date:  2011-07-12       Impact factor: 7.580

3.  Reductions in Fatigue Predict Occupational Re-engagement in Individuals with Work-Related Musculoskeletal Disorders.

Authors:  Keiko Yamada; Heather Adams; Tamra Ellis; Robyn Clark; Craig Sully; Michael J L Sullivan
Journal:  J Occup Rehabil       Date:  2020-03

4.  Reliability and structural validity of the Multidimensional Fatigue Inventory (MFI) in patients with idiopathic Parkinson's disease.

Authors:  Roy G Elbers; Erwin E H van Wegen; John Verhoef; Gert Kwakkel
Journal:  Parkinsonism Relat Disord       Date:  2012-02-22       Impact factor: 4.891

Review 5.  Classical and unusual imaging appearances of melorheostosis.

Authors:  S Suresh; T Muthukumar; A Saifuddin
Journal:  Clin Radiol       Date:  2010-04-18       Impact factor: 2.350

6.  Distinct Clinical and Pathological Features of Melorheostosis Associated With Somatic MAP2K1 Mutations.

Authors:  Smita Jha; Nadja Fratzl-Zelman; Paul Roschger; Georgios Z Papadakis; Edward W Cowen; Heeseog Kang; Tanya J Lehky; Katharine Alter; Zuoming Deng; Aleksandra Ivovic; Lauren Flynn; James C Reynolds; Abhijit Dasgupta; Markku Miettinen; Eileen Lange; James Katz; Klaus Klaushofer; Joan C Marini; Richard M Siegel; Timothy Bhattacharyya
Journal:  J Bone Miner Res       Date:  2018-09-14       Impact factor: 6.741

7.  Fatigue is a frequent and clinically relevant problem in Ehlers-Danlos Syndrome.

Authors:  Nicol C Voermans; Hans Knoop; Nicole van de Kamp; Ben C Hamel; Gijs Bleijenberg; Baziel G van Engelen
Journal:  Semin Arthritis Rheum       Date:  2009-10-30       Impact factor: 5.532

8.  Melorheostosis: A Clinical, Pathologic, and Radiologic Case Series.

Authors:  Cameron N Fick; Nadja Fratzl-Zelman; Paul Roschger; Klaus Klaushofer; Smita Jha; Joan C Marini; Timothy Bhattacharyya
Journal:  Am J Surg Pathol       Date:  2019-11       Impact factor: 6.394

9.  The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue.

Authors:  E M Smets; B Garssen; B Bonke; J C De Haes
Journal:  J Psychosom Res       Date:  1995-04       Impact factor: 3.006

Review 10.  Molecular, phenotypic aspects and therapeutic horizons of rare genetic bone disorders.

Authors:  Taha Faruqi; Naveen Dhawan; Jaya Bahl; Vineet Gupta; Shivani Vohra; Khin Tu; Samir M Abdelmagid
Journal:  Biomed Res Int       Date:  2014-10-22       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.